Growth Metrics

Catalyst Pharmaceuticals (CPRX) Share-based Compensation Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 206.26%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -69.95%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 0.18%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.66%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 23.70%
10 Catalyst Pharmaceuticals 3.82 Bn 3.07 Bn 134.92 Mn 7.01%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 7.01%
Dec 31, 2025 9.48%
Sep 30, 2025 28.16%
Jun 30, 2025 72.35%
Mar 31, 2025 -29.07%
Dec 31, 2024 21.67%
Sep 30, 2024 16.12%
Jun 30, 2024 33.66%
Mar 31, 2024 185.20%
Dec 31, 2023 120.66%
Sep 30, 2023 85.40%
Jun 30, 2023 63.03%
Mar 31, 2023 51.97%
Dec 31, 2022 30.84%
Sep 30, 2022 35.91%
Jun 30, 2022 33.27%
Mar 31, 2022 21.13%
Dec 31, 2021 0.20%
Sep 30, 2021 2.30%
Jun 30, 2021 -15.38%
Mar 31, 2021 3.42%
Dec 31, 2020 27.79%
Sep 30, 2020 80.89%
Jun 30, 2020 93.95%
Mar 31, 2020 62.74%
Dec 31, 2019 11.65%
Sep 30, 2019 7.77%
Jun 30, 2019 16.87%
Mar 31, 2019 -3.90%
Dec 31, 2018 112.07%
Sep 30, 2018 43.12%
Jun 30, 2018 23.95%
Mar 31, 2018 28.80%
Dec 31, 2017 -0.64%
Sep 30, 2017 -0.46%
Jun 30, 2017 78.74%
Mar 31, 2017 64.67%
Dec 31, 2016 -15.22%
Sep 30, 2016 60.90%
Jun 30, 2016 -1.82%
Mar 31, 2016 45.64%
Dec 31, 2015 100.37%
Sep 30, 2015 -25.61%
Jun 30, 2015 1,512.30%
Mar 31, 2015 1,259.49%
Dec 31, 2014 576.01%
Sep 30, 2014 852.80%
Jun 30, 2014 -49.72%
Mar 31, 2014 -44.60%
Dec 31, 2013 -79.17%
Sep 30, 2013 2.37%
Jun 30, 2013 -0.45%
Mar 31, 2013 -7.40%
Dec 31, 2012 -17.94%
Sep 30, 2012 -6.94%
Jun 30, 2012 -30.71%
Mar 31, 2012 -16.11%
Dec 31, 2011 1.20%
Sep 30, 2011 36.18%